1Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis, 2002,2(12) :721.
2Moller AS, Bjerre A, Brusletto B,et al. Chemokine patterns in meningococcal disease. J Infect Dis, 2005,191 (5) :768.
3Zwijnenburg PJG, de Bie HMA, Roord JJ, et al. Chemotactic activity of CXCL5 in cerebrospinal fluid of child with bacterial meningitis. J Neuroimmunol, 2003,145 ( 1-2 ): 148.
4Goodman RB, Strieter RM, Frevert CW, et al. Quantitative comparison of C-X-C chemokines produced by endotoxinstimulated human alveolar macrophages. Am J Physiol,1998,275(1 Pt 1) :L87.
5Ostergaard C, Yieng-Kow RV, Benfield T, et al. Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis inrabbits[J]. Infect Immun, 2000, 68(6): 3153-3157.
6Lahrtz F, Piali L, Spanaus KS, et al. Chemokines and chemotaxis of leukocytes in infectious meningitis[J]. J Neuroimmunol,1998, 85(1): 33-43.
7Walport MJ. Complement. First of two parts[J].N Engl J Med,2001, 344(14): 1058-1066.
8Wing MG, Seilly DJ, Nicholas RS, et al. Comparison of Clq-receptors on rat microglia and peritoneal macrophages[J]. J Neuroimmunol, 1999, 94(1-2): 74-81.
9Rovai LE, Herschman HR, Smith JB. The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia[J]. J Leukoc Biol, 1998, 64(4): 494-502.
10Nau R, Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy[J].Trends Neurosci, 2002,25(1):38-45.
